|Articles|March 1, 2004
Cohesive agent performs reliably in all stages of surgery
Cataract surgeons who choose sodium hyaluronate 1.2% (StaarVisc II, STAAR Surgical) for their routine cases know they can rely on it from beginning to end to offer all the features they seek in a viscoelastic.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SparingVision completes PRODYGY trial patient dosing with SPVN06
2
Angiogenesis 2026: Continuous AI severity scoring could transform AMD monitoring
3
4DMT completes enrollment in 4FRONT-1, phase 3 trial of 4D-150 in AMD
4
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
5
























